2 Japanese medicines considered important for the treatment of corona virus

Work is underway around the world to find a cure for the new novel coronavirus, code 19, and two Japanese drugs are considered important.

Favipiravir, a drug used for influenza, and chemostat, a drug used to treat pancreatitis for 35 years, are considered important in this regard, with interest from scientists in Japan and other countries. Showing

Remediators developed by Gilad Science have been found to be effective in treating the virus in various research reports, which have since been approved for emergency use in the United States and Japan.

Although the use of this drug helps the skin of patients undergoing treatment in the hospital, further treatment options are being explored.

Scientists' interest in the drug Fuviperavir, developed by Fuji Film's Toma Chemical Company, grew when a study in China revealed the results in March.

Testing of the drug in China began in February and its clinical trial was approved on March 15, and officials say its effects on patients so far have been encouraging.

During a study in Shenzhen in February, 320 patients with code 19 were given the drug, and the researchers found that it cleared the virus in an average of 4 days, compared to 11 days with other drugs. ۔

More than 91% of patients using the drug also showed improvement in lung condition, compared to 63% in the other group.

The researchers said that these data show that the drug cleans the virus faster, with fewer side effects discovered so far.

The trial of the drug for the treatment of cod began in Russia last month, and preliminary results have been hailed as encouraging.

On May 13, the Russian Direct Investment Fund (RDIF) reported that the results of initial clinical trials of the drug had been excellent.

During the trial, 60 percent of coronavirus patients were treated with the drug and recovered within five days, said RDIF chief Karl Dimitrov. Time reduced by 50%.

Russia has the second highest number of patients with COD 19 after the United States, with research on 330 patients expected to be completed by the end of May, and researchers say it could help account for 50 percent of all sick people. Can be reduced.

Early tests have shown minor side effects and have been discontinued for pregnant women, she said.

Trials of this drug in India have also entered the third phase.

The drug is being supplied by Japanese Prime Minister Abe Shinzo to 43 countries for the treatment of corona virus patients, and the Japanese government may approve its use later this month following the results of trials.

Fuji's filmmaker said the use of the drug would depend on doctors and scientific findings
The drug was developed by a company in the late 1990s and later bought by Fuji Film and is used against a type of influenza that is not affected by other drugs.

The drug was used in 2014 by Doctors Without Borders in collaboration with the World Health Organization to treat Ebola patients in Africa.

Research in Guyana found that when the drug was administered to moderately ill people, the mortality rate dropped from 30% to 15%.

Now the Japanese government expects the same benefits to be reaped against Code 19.

This medicine is used in pill form and therefore may be more readily available than the remediator that is given in the form of an injection.

The Japanese drug is also considered harmful to pregnant women, but it was allowed to be used in Japan in 2014 as an emergency, while China was given a license to manufacture it.

Another drug, chemostat, is used to treat pancreatitis and various types of cancer, but in the past, laboratory and animal trials have shown that it is effective against the stork corona virus.

A study published in the journal Cell in March of this year found that the drug could block an enzyme that helps the corona virus enter the lungs.

Dr. Joseph Venetz of the Yale School of Medicine was part of the study and is now starting a clinical trial of the drug.

It should be noted that at present there is no cure for code 19 but its symptoms are treated with different drugs depending on their nature and the World Health Organization says that 97% of patients recover.

Vaccines are being developed in different countries for this purpose
Research at the University of Connecticut in the United States is also using the drug to see if it can prevent the virus from entering human cells, with hydroxychloroquine being part of the study.